SCHEMBL3377154

SCHEMBL3377154

Clc1ccc(CN2CCOCC2)c(-c2cccs2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A13 Q16696 4/20 0.58
HTT P42858 3/20 0.51
SLC2A1 P11166 1/20 0.48
PIK3CD O00329 1/20 0.45
PRKDC P78527 1/20 0.45
KDM4E B2RXH2 2/20 0.44
HIF1A Q16665 1/20 0.44
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
DRD4 P21917 1/20 0.44
DRD5 P21918 1/20 0.44
F2 P00734 1/20 0.44
F10 P00742 1/20 0.44
CYP2C9 P11712 1/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
RAB9A P51151 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 2/20 0.43
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3374256 0.86 CXCR3 (0.42) CYP2A13HTTKDM4EDRD4DRD5
SCHEMBL4109682 0.74 CYP2A13 (1.00) CYP2A13HTTKDM4EHIF1ACYP2C9
SCHEMBL9197772 0.74 HTT (0.54) CYP2A13HTTSLC2A1PRKDCADORA2A
SCHEMBL21462386 0.72 HRH3 (0.65) CYP2A13HTTSLC2A1KDM4EHIF1A
SCHEMBL9424160 0.72 CYP2A13 (0.71) CYP2A13HTTKDM4EHIF1ACYP2C9
SCHEMBL4243681 0.72 CYP2A13 (0.71) CYP2A13HTTKDM4EHIF1ACYP2C9
SCHEMBL8151479 0.71 CYP2A13 (0.69) CYP2A13HTTKDM4EHIF1ACYP2C9
SCHEMBL3344984 0.70 NPC1 (0.49) CYP2A13KDM4EDRD4DRD5RAB9A
SCHEMBL3345662 0.70 SLC2A1 (0.52) CYP2A13HTTSLC2A1KDM4EADORA2A
SCHEMBL21462427 0.69 DRD2 (0.55) HTTSLC2A1PRKDCKDM4EADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010045006-A1 METHYLENE AMINES OF THIENO [2,3-D] PYRIMIDINE AND THEIR USE AS ADENOSINE A2A RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2010-04-22 WO disclosed